Clinical Trial Update: A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in Adults [Phase 1]

View source ↗

Summary

Phase I trial of the AERAS 404 tuberculosis vaccine in adults has completed, assessing safety and immunogenicity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• AERAS 404

Snippet

Sponsor: Aeras | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED